Respiratory Syncytial Virus Immunization

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-08-05
Clinical Trial Results: Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older [Phase 1, Phase 2]
Phase 1/2 trial results for an RSV vaccine candidate encapsulated in a lipid nanoparticle formulation in adults 18-50 and 60+ completed with…